Search results
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks via Yahoo Finance· 6 days agoIn August 2023, the FDA approved Eylea HD (higher dose of Eylea) for the treatment of patients with...
EyePoint Pharmaceuticals stock target cut, retains Buy rating By Investing.com
Investing.com· 1 day agoThe reduction follows a significant 43% drop in EyePoint's share value on Monday, which contrasted...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoJohnson & Johnson Highlights Commitment to Transform Treatment of Retinal Diseases at ARVO 2024 PR Newswire RARITAN, N.J., May 3, 2024 Company to present, across eight data ...
Nanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World...
FOX 5 San Diego· 1 day agoDALLAS, May 7, 2024 /PRNewswire/ -- Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today announced that ...
Clarifeye Total Eye Care expands to Shenandoah, offering personalized eye care services
Community Impact· 3 days agoResidents in Shenandoah and southern Montgomery County have a new option for personalized eye care...
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
Benzinga· 2 days agoThe data demonstrated that Duravyu has a biologic effect in patients with NPDR and a favorable safety and tolerability profile; however, the trial did not meet the pre-specified primary endpoint ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 day agoGenerated $172.3 million in 1Q 2024 revenues, including $163.1 million in U.S. net product sales $137.5 million for SYFOVRE® (pegcetacoplan injection) $25.6 million for EMPAVELI® (pegcetacoplan) Anticipates CHMP opinion for pegcetacoplan in GA
Head to Head Survey: Cognition Therapeutics (NASDAQ:CGTX) vs. Opthea (NASDAQ:OPT)
ETF DAILY NEWS· 4 days agoCognition Therapeutics (NASDAQ:CGTX – Get Free Report) and Opthea (NASDAQ:OPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the ...
Santa J. Ono, University of Michigan President, Joins USJF Board
The Longview News-Journal· 23 hours agoSanta J. Ono, president of the University of Michigan, has joined the United States-Japan Foundation Board of Trustees. Ono, an accomplished medical researcher and leader in higher education ...
REGENXBIO (NASDAQ:RGNX) Downgraded by StockNews.com to “Sell”
ETF DAILY NEWS· 11 hours agoStockNews.com cut shares of REGENXBIO (NASDAQ:RGNX – Free Report) from a hold rating to a sell rating in a report published on Tuesday. Chardan Capital reaffirmed a buy rating and set a $52.00 ...